Saúde Pública em Pediatria
Novavax afirma que vacina proteica funciona para crianças a partir dos 12 anos de idade.
14 Fev, 2022 | 16:16hNovavax says protein vaccine works for kids as young as 12 – Associated Press
Comunicado de imprensa: Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
Conteúdos relacionados:
Opinion | The mRNA vaccines are extraordinary, but Novavax is even better.
RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.
New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
Pfizer e FDA recuam em relação ao plano para agilizar a avaliação de vacinas contra Covid-19 em crianças menores de 5 anos.
14 Fev, 2022 | 16:14hPfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in young children – STAT
Ver também:
COVID-19 vaccine for kids under 5 delayed as Pfizer extends trial – CIDRAP
Pfizer postpones FDA request for Covid vaccine for kids under 5 – NBC News
Primeira definição para “long Covid” em crianças e jovens é formalmente elaborada.
14 Fev, 2022 | 16:10hComunicado de imprensa: First research definition for ‘Long COVID’ in kids and young people formally agreed – BMJ
Artigo original (preprint): Long COVID (Post-COVID-19 condition) in Children: a modified Delphi Process – Archives of Disease in Childhood
Comentários:
Long covid: “Holistic” approach is best, given range of symptoms, say researchers – The BMJ
Conteúdos relacionados:
Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.
Review: Long COVID symptoms in children rarely persist beyond three months.
Edição especial | Estratégias baseadas em evidências para melhor prescrição de antibióticos na atenção primária.
14 Fev, 2022 | 16:07hEditorial: Antibiotic stewardship – Australian Journal of General Practice
Evidence-based strategies for better antibiotic prescribing – Australian Journal of General Practice
Bebês nascidos durante o primeiro ano da pandemia tiveram um escore levemente menor em testes de avaliação de desenvolvimento.
11 Fev, 2022 | 14:21hComunicado de imprensa: Babies born during pandemic’s first year score slightly lower on a developmental screening test – Columbia University Irving Medical Center
Editorial: Understanding the Effects of the Pandemic on Infant Development—The Preterm Problem
Comentários:
Covid-19: Babies born during the pandemic show slight development delays – The BMJ
Pandemic birth tied to poor development – CIDRAP
Estudo de coorte | Saúde mental e física 3 meses depois da infecção por SARS-CoV-2 (“long COVID”) entre adolescentes na Inglaterra.
10 Fev, 2022 | 13:15hComentário: Long COVID and kids: more research is urgently needed – Nature
Conteúdos relacionados:
Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.
Review: Long COVID symptoms in children rarely persist beyond three months.
Comentário no Twitter (fio – clique para saber mais)
NEW RESEARCH: free! Two studies on adolescent #LongCovid. Both found high symptom burden in COVID positive and negative participants; very heterogenous symptom profile. Pandemic has had profound impact on all adolescents. https://t.co/YzU3ogXZrw pic.twitter.com/ina0DgPxBf
— The Lancet Child & Adolescent Health (@LancetChildAdol) February 8, 2022
[Preprint] Vigilância ativa de miocardite e pericardite decorrentes da vacinação contra COVID-19 com vacinas do tipo mRNA em pessoas de 12-39 anos na Itália.
10 Fev, 2022 | 13:13hConteúdos relacionados:
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Comentário no Twitter
The incidence of mRNA vaccine myocarditis or pericarditis in Italy in ~3 million vaccinees age 12-39. Excess cases per 100,000; orange is 2nd dose, blue 1st dose. https://t.co/xvdV4qSdHw
Pfizer:~1/100,000 age 12-39, all 2nd dose
Moderna,: >5/100,000, age 12-39, and some 1st dose pic.twitter.com/Y1jfGrU53v— Eric Topol (@EricTopol) February 9, 2022
Apesar de raro, o risco de inflamação cardíaca foi maior em quem recebeu vacina contra Covid da Moderna do que naqueles que receberam a dose da Pfizer.
10 Fev, 2022 | 13:11hConteúdos relacionados:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Especialistas questionam uma proposta incomum para autorizar vacinação contra Covid em crianças menores de 5 anos.
4 Fev, 2022 | 17:30hExperts question unusual authorization plan for Covid vaccine for kids under 5 – STAT
Conteúdos relacionados:
Pfizer asks FDA to allow COVID-19 vaccine for kids under 5 – Associated Press
Pfizer Asks FDA to Approve Its Vaccine for the Youngest Children – HealthDay
M-A | Desfechos do parto de neonatos expostos a maconha in utero.
4 Fev, 2022 | 15:40hComentário convidado: Reexamining Risks of Prenatal Cannabis Use—Mounting Evidence and a Call to Action – JAMA Network Open
Comentário no Twitter
This systematic review and meta-analysis found that prenatal marijuana exposure is associated with increases in many adverse neonatal outcomes, including lower birth weight and preterm delivery. @MarchandSurgery @tmcaznews https://t.co/qvWOWu4Dkc
— JAMA Network Open (@JAMANetworkOpen) January 27, 2022